Mitoxantrone
Showing 51 - 75 of 438
Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)
Completed
- Acute,Leukemia, Lymphoid
- Dasatinib
- +12 more
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Aug 2, 2022
Relapsed Adult AML, Refractory AML Trial in Milwaukee (Navitoclax Dose Level -1, Navitoclax Dose Level 0, Navitoclax Dose Level
Not yet recruiting
- Relapsed Adult AML
- Refractory AML
- Navitoclax Dose Level -1
- +10 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Aug 17, 2023
Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Mitoxantrone hydrochloride liposome injection
- +4 more
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Aug 15, 2023
Leukemia Trial in Shanghai (CLAM+PBSC)
Suspended
- Leukemia
-
Shanghai, ChinaRui Jin Hospital, Department of Hematology
Nov 23, 2021
Platinum-resistant Ovarian Cancer Trial in China (Mitoxantrone Hydrochloride Liposome, intravenous injection (IV))
Recruiting
- Platinum-resistant Ovarian Cancer
- Mitoxantrone Hydrochloride Liposome, intravenous injection (IV)
-
Chongqing, Chongqing, China
- +6 more
May 31, 2021
Advanced Gastric Carcinoma Trial in China (Mitoxantrone Hydrochloride Liposome, intravenous injection)
Recruiting
- Advanced Gastric Carcinoma
- Mitoxantrone Hydrochloride Liposome, intravenous injection
-
Beijing, Beijing, China
- +8 more
May 31, 2021
Drug/Agent Toxicity by Tissue/Organ, Leukemia, MDS Trial in Chicago, Kankakee (amifostine trihydrate, cytarabine, mitoxantrone
Withdrawn
- Drug/Agent Toxicity by Tissue/Organ
- +3 more
- amifostine trihydrate
- +2 more
-
Chicago, Illinois
- +3 more
Jan 31, 2023
Non-Hodgkins Lymphoma Trial in Fort Myers, Nashville (Cyclophosphamide, Mitoxantrone, Vincristine)
Advanced Hepatocellular Carcinoma Trial (Liposome-entrapped Mitoxantrone Hydrochloride Injection)
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- Liposome-entrapped Mitoxantrone Hydrochloride Injection
- (no location specified)
Jun 14, 2021
Leukemia Trial in Chicago, Kankakee (recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine)
Withdrawn
- Leukemia
- recombinant interferon alfa
- +7 more
-
Chicago, Illinois
- +3 more
Oct 6, 2021
Peripheral T Cell Lymphoma Trial in Guangzhou (Mitoxantrone Hydrochloride Liposome Injection, Chidamide)
Not yet recruiting
- Peripheral T Cell Lymphoma
- Mitoxantrone Hydrochloride Liposome Injection
- Chidamide
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Dec 11, 2020
Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,
Completed
- Non-Hodgkin's Lymphoma
- Etoposide, carboplatin, ifosfamide
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 23, 2022
Acute Myeloid Leukemia Trial in Germany (HAM, LDAC and/or Mitoxantrone)
Completed
- Acute Myeloid Leukemia
- HAM
- LDAC and/or Mitoxantrone
-
Heidelberg, Baden-Wuerttemberg, Germany
- +17 more
Aug 2, 2022
Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS Trial in Buffalo (Mitoxantrone)
Completed
- Neuromyelitis Optica
- +3 more
- Mitoxantrone
-
Buffalo, New YorkBaird Multiple Sclerosis Center
Dec 23, 2020
Solid Tumours, CNS Tumours Trial in Randwick, Westmead (Mitoxantrone packaged EDV (EnGeneIC Delivery Vehicle))
Terminated
- Solid Tumours
- CNS Tumours
- Mitoxantrone packaged EDV (EnGeneIC Delivery Vehicle)
-
Randwick, New South Wales, Australia
- +1 more
Jan 30, 2022
Acute Myeloid Leukemia Trial in Worldwide (Alvocidib, Cytarabine, Mitoxantrone)
AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed
Recruiting
- AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
- MRD-triggered arm
- Prophylactic Arm
-
Heidelberg, BW, GermanyUniversity Hospital Heidelberg Med5
Jan 4, 2021
Lymphoma Trial in Houston (Fludarabine, Novantrone, Decadron)
Completed
- Lymphoma
- Fludarabine
- +14 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 22, 2020
Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia Trial in
Recruiting
- Recurrent Adult Acute Myeloid Leukemia
- +2 more
- Sirolimus
- +3 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Dec 7, 2020
Acute Myeloid Leukemia Trial in Ulm (chemo (Mitoxantrone, Cytarabine), Placebo, Crenolanib)
Terminated
- Acute Myeloid Leukemia
- chemotherapy (Mitoxantrone, Cytarabine)
- +3 more
-
Ulm, GermanyUlm University Hospital
Sep 28, 2021
Breast Cancer Trial in China (Mitoxantrone Hydrochloride Liposome Injection)
Recruiting
- Breast Cancer
- Mitoxantrone Hydrochloride Liposome Injection
-
Hefei, Anhui, China
- +28 more
Jun 15, 2021
Multiple Sclerosis Trial in Isfahan (plasmapheresis)
Completed
- Multiple Sclerosis
- plasmapheresis
-
Isfahan, Iran, Islamic Republic ofAlahra hospital
Aug 27, 2020
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022